亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。

STRUCTURED VIRAL PEPTIDE COMPOSITIONS AND METHODS OF USE

技术优势
HIV/AIDS, viral infections
技术应用
The present invention is directed to compositions, kits and methods utilizing structurally constrained viral peptides. The compositions are useful for treating and/or preventing viral infections as vaccines and to generate antibodies against the structurally constrained peptides that are isolated and used as preventive and/or therapeutic agents.
详细技术说明
Hydrocarbon-stapled, alpha-helical viral peptides have excellent structural, proteolytic, acid, and thermal stability, and are highly effective in interfering with virus/cell fusion. A combined strategy of structural data analysis and chemical synthesis was applied to construct membrane proximal external region -based and heptad repeat domain ¬based HIV-1 gp4l immunogens. The invention encompasses the composition and functional validation of gp4l-based stapled peptides, termed Stabilized Antigenic Structures of gp4l (SAS-gp4l), designed to faithfully recapitulate immunogenic features of HIV-1, such that broadly neutralizing anti-HIV-1 antibodies can be elicited upon SAS-gp4l vaccination.
*Abstract
The present invention is directed to compositions, kits and methods utilizing structurally constrained viral peptides.
附加资料
Inventor: WALENSKY, Loren, D. | BIRD, Gregory
Priority Number: WO2010148335A2
IPC Current: A61K003942
Assignee Applicant: Dana Farber Cancer Institute Inc.
Title: STRUCTURED VIRAL PEPTIDE COMPOSITIONS AND METHODS OF USE | COMPOSITIONS DE PEPTIDES VIRAUX STRUCTURÉS ET PROCÉDÉS D'UTILISATION
Usefulness: STRUCTURED VIRAL PEPTIDE COMPOSITIONS AND METHODS OF USE | COMPOSITIONS DE PEPTIDES VIRAUX STRUCTURÉS ET PROCÉDÉS D'UTILISATION
Summary: For inhibition or suppression of viral fusion or viral infectivity; for promoting an immune response; for prevention, amelioration, or treatment of a viral infection including HIV infection (claimed) and AIDS; and as vaccine.
Novelty: New structurally constrained peptide comprising specific amino acids of membrane-proximal ectodomain region domain or specific amino acids of heptad repeat domain-2 sequence, for treating viral infection e.g. HIV infection and AIDS
主要类别
诊断/治疗
细分类别
人类免疫缺陷病毒
国家/地区
美国

欲了解更多信息,请点击 这里
移动设备